FDA Import Refusal AEK-5494660-1/11/1 — Johnson & Johnson Ltd
The FDA refused shipment AEK-5494660-1/11/1 from Johnson & Johnson Ltd (United Kingdom) on Aug 2, 2024. The refused product falls under Drugs and Biologics — ACRIVASTINE/PSEUDOEPHEDRINE HCL (ANTI-HISTAMINIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Aug 2, 2024
- Country
- United Kingdom
- Product Category
- Drugs and Biologics
- Product Code
- 61XDY41 ACRIVASTINE/PSEUDOEPHEDRINE HCL (ANTI-HISTAMINIC)
- Charges
- 75